UBS Group
ATHE

UBS Group’s Alterity Therapeutics ATHE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,004
Closed -$44.9K 8900
2025
Q1
$44.9K Buy
13,004
+12,620
+3,286% +$43.5K ﹤0.01% 6382
2024
Q4
$1.27K Sell
384
-12,301
-97% -$40.7K ﹤0.01% 8031
2024
Q3
$16.6K Buy
12,685
+12,683
+634,150% +$16.6K ﹤0.01% 6264
2024
Q2
$4 Hold
2
﹤0.01% 8236
2024
Q1
$4 Buy
+2
New +$4 ﹤0.01% 7975
2023
Q4
Sell
-127
Closed -$315 8056
2023
Q3
$315 Buy
+127
New +$315 ﹤0.01% 7441
2022
Q2
Sell
-10,487
Closed -$9K 9228
2022
Q1
$9K Sell
10,487
-3,112
-23% -$2.67K ﹤0.01% 7474
2021
Q4
$10K Buy
+13,599
New +$10K ﹤0.01% 7633
2021
Q3
Sell
-4,658
Closed -$6K 8339
2021
Q2
$6K Buy
4,658
+4,588
+6,554% +$5.91K ﹤0.01% 7319
2021
Q1
$0 Sell
70
-1,845
-96% ﹤0.01% 7902
2020
Q4
$3K Buy
1,915
+1,677
+705% +$2.63K ﹤0.01% 6950
2020
Q3
$0 Sell
238
-52,876
-100% ﹤0.01% 7062
2020
Q2
$63K Buy
53,114
+50,037
+1,626% +$59.4K ﹤0.01% 4842
2020
Q1
$2K Buy
3,077
+3,007
+4,296% +$1.96K ﹤0.01% 6670
2019
Q4
$0 Sell
70
-2,282
-97% ﹤0.01% 7007
2019
Q3
$3K Sell
2,352
-3,987
-63% -$5.09K ﹤0.01% 6646
2019
Q2
$8K Buy
6,339
+4,269
+206% +$5.39K ﹤0.01% 6295
2019
Q1
$4K Sell
2,070
-8,041
-80% -$15.5K ﹤0.01% 6407
2018
Q4
$13K Buy
10,111
+2,378
+31% +$3.06K ﹤0.01% 6157
2018
Q3
$16K Buy
7,733
+6,359
+463% +$13.2K ﹤0.01% 5998
2018
Q2
$3K Sell
1,374
-4,702
-77% -$10.3K ﹤0.01% 6686
2018
Q1
$13K Buy
6,076
+1,210
+25% +$2.59K ﹤0.01% 5821
2017
Q4
$15K Buy
4,866
+897
+23% +$2.77K ﹤0.01% 5783
2017
Q3
$11K Buy
3,969
+3,591
+950% +$9.95K ﹤0.01% 5905
2017
Q2
$1K Sell
378
-3,198
-89% -$8.46K ﹤0.01% 6520
2017
Q1
$11K Buy
3,576
+3,134
+709% +$9.64K ﹤0.01% 5618
2016
Q4
$1K Sell
442
-4,748
-91% -$10.7K ﹤0.01% 6602
2016
Q3
$23K Buy
5,190
+4,590
+765% +$20.3K ﹤0.01% 5294
2016
Q2
$3K Sell
600
-5,374
-90% -$26.9K ﹤0.01% 6399
2016
Q1
$17K Sell
5,974
-16,698
-74% -$47.5K ﹤0.01% 5474
2015
Q4
$16K Buy
22,672
+22,452
+10,205% +$15.8K ﹤0.01% 5718
2015
Q3
$0 Buy
+220
New ﹤0.01% 6835
2015
Q1
Sell
-3,215
Closed -$6K 6652
2014
Q4
$6K Buy
+3,215
New +$6K ﹤0.01% 6245